Not for concomitant use w/ hormonal contraceptives of any form (tab, patch, IUD). Not a contraceptive. Patient or family history of VTE at a relatively early age. Family history of breast cancer. History of depression. Patients w/ high BP or who developed high BP & hepatic disease, or suffering from lower abdominal pain during therapy. Diabetes. Temporary diabetes during previous pregnancy. Avoid too much sun or UV radiation exposure in patients who had chloasma. May worsen benign uterine tumours; discontinue when anemia occurs during treatment. Possible changes in menstrual bleeding pattern. Increased risk of VTE in the elderly, patients who are overwt, has or w/ family history of thrombosis, embolism or pulmonary embolism at an early age, for surgery or w/ history of serious accident or is on a long-term immobilization. Increased risk of stroke in women w/ HTN. Increased risk of arterial blood clot in smokers, overwt, patient or family history of heart attack or stroke at a young age, patients w/ HTN. Regularly monitor for breast lumps. Patients w/ glucose intolerance. May affect the result of blood tests. Development of hepatic disease during therapy. Patients w/ hepatic disease symptoms during previous pregnancy. Reduced chances of pregnancy during therapy. Increased risk of extrauterine pregnancy when taken during pregnancy. Possible risk of osteoporosis in adolescents <18 yr. Not for girls premenarche.
Sign Out
